BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25695679)

  • 1. Thymosin β4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition.
    Fu X; Cui P; Chen F; Xu J; Gong L; Jiang L; Zhang D; Xiao Y
    Mol Med Rep; 2015 Jul; 12(1):127-32. PubMed ID: 25695679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.
    Hong KO; Lee JI; Hong SP; Hong SD
    Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway.
    Piao Z; Hong CS; Jung MR; Choi C; Park YK
    Biochem Biophys Res Commun; 2014 Sep; 452(3):858-64. PubMed ID: 25218472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.
    Huang HC; Hu CH; Tang MC; Wang WS; Chen PM; Su Y
    Oncogene; 2007 Apr; 26(19):2781-90. PubMed ID: 17072345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.
    Assmann G; Kappler R; Zeindl-Eberhart E; Schmid I; Häberle B; Graeb C; Jung A; Müller-Höcker J
    Hum Pathol; 2012 Nov; 43(11):1815-27. PubMed ID: 22749188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis.
    Morita T; Hayashi K
    Mol Cancer Res; 2018 May; 16(5):880-893. PubMed ID: 29330296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients.
    Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX; Gao S
    Neoplasma; 2016; 63(6):991-998. PubMed ID: 27596300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin β4: a potential molecular target for tumor therapy.
    Xiao Y; Chen Y; Wen J; Yan W; Zhou K; Cai W
    Crit Rev Eukaryot Gene Expr; 2012; 22(2):109-16. PubMed ID: 22856429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells.
    Kim A; Son M; Kim KI; Yang Y; Song EY; Lee HG; Lim JS
    Exp Cell Res; 2009 Nov; 315(19):3325-35. PubMed ID: 19500569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin β4 expression reveals intriguing similarities between fetal and cancer cells.
    Faa G; Nemolato S; Cabras T; Fanni D; Gerosa C; Fanari M; Locci A; Fanos V; Messana I; Castagnola M
    Ann N Y Acad Sci; 2012 Oct; 1269():53-60. PubMed ID: 23045970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.
    Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z
    J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
    Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer.
    Yoon SY; Lee HR; Park Y; Kim JH; Kim SY; Yoon SR; Lee WJ; Cho BJ; Min H; Bang JW; Park H; Bang SI; Cho D
    Oncol Rep; 2011 Jan; 25(1):23-31. PubMed ID: 21109953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.